Abstract
Mg2+ plays important roles in numerous cellular functions. Mitochondria take part in intracellular Mg2+ regulation and the Mg2+ concentration in mitochondria affects the synthesis of ATP. However, there are few methods to observe Mg2+ in mitochondria in intact cells. Here, we have developed a novel Mg2+–selective fluorescent probe, KMG-301, that is functional in mitochondria. This probe changes its fluorescence properties solely depending on the Mg2+ concentration in mitochondria under physiologically normal conditions. Simultaneous measurements using this probe together with a probe for cytosolic Mg2+, KMG-104, enabled us to compare the dynamics of Mg2+ in the cytosol and in mitochondria. With this method, carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP)–induced Mg2+ mobilization from mitochondria to the cytosol was visualized. Although a FCCP–induced decrease in the Mg2+ concentration in mitochondria and an increase in the cytosol were observed both in differentiated PC12 cells and in hippocampal neurons, the time-courses of concentration changes varied with cell type. Moreover, the relationship between mitochondrial Mg2+ and Parkinson's disease was analyzed in a cellular model of Parkinson's disease by using the 1-methyl-4-phenylpyridinium ion (MPP+). A gradual decrease in the Mg2+ concentration in mitochondria was observed in response to MPP+ in differentiated PC12 cells. These results indicate that KMG-301 is useful for investigating Mg2+ dynamics in mitochondria. All animal procedures to obtain neurons from Wistar rats were approved by the ethical committee of Keio University (permit number is 09106-(1)).
Introduction
The magnesium ion (Mg2+) is an essential cation for maintaining proper cellular activities. For example, Mg2+ is an essential cofactor for hundreds of enzymes [1], [2], the intracellular concentration of Mg2+ ([Mg2+]i) regulates several types of ion channels [3], [4], and Mg2+ plays an important role in energy metabolism [5], [6]. [Mg2+]i is usually maintained in the range of 0.5–0.7 mM, not only by Mg2+ transport across the cell membrane, but also by intracellular buffering and compartmentation into organelles in the majority of mammalian cells [7]. In diseased states, or under the administration of certain hormonal stimuli or cAMP signaling agents, remarkable alterations in [Mg2+]i are observed [2], [8], [9]. Therefore, it is important to investigate cellular Mg2+ transport and concentration changes in the cytosol and in organelles to better understand intracellular signaling and the pathogenesis of some types of diseases. Because of the absence of Mg2+ selective indicators, however, the changes in [Mg2+]i in cells and organelles are still not well understood. Commercially available fluorescent Mg2+ probes are also sensitive to changes in the intracellular Ca2+ concentration, and therefore, those probes are often used as Ca2+ indicators [10], [11], [12]. In our group, novel Mg2+ selective fluorescent probes, the KMG series, have been developed [13], [14]. These probes are selective for Mg2+ and other ions present at physiological concentrations have no effect on their fluorescence. Using these probes, changes in [Mg2+]i were measured in many types of cells [15], [16], [17], and it was demonstrated that mitochondria play an important role in intracellular Mg2+ dynamics [18], [19].
Mitochondria are the organelles responsible for the cellular energy metabolism, and it was reported that ATP synthesis in mitochondria is regulated by the Mg2+ concentration in mitochondria [20]. Mitochondria accumulate Mg2+ using their inner membrane potential via Mrs2, which is a Mg2+–selective channel expressed in the mitochondrial inner membrane [21], [22]. Mitochondria also transport Mg2+ bound to ATP via the ATP–Mg/Pi carrier in the mitochondrial inner membrane. This exchanger mediates the electroneutral influx and efflux of ATP–Mg in exchange for Pi [23]. Because the depolarization of the mitochondrial inner membrane potential induces the release of Mg2+ from mitochondria [18], it is likely that the dysfunction of mitochondria and the disorder of cellular Mg2+ regulation are strongly related. Actually, such malfunctions are reported in many neuronal diseases, such as migraine, Alzheimer's disease and Parkinson's disease (PD) [24], [25], [26], [27]. These evidences indicate that the investigation of Mg2+ concentration changes in mitochondria is important to understand the detailed mechanisms in intracellular signaling and pathogenesis of such diseases. However, few techniques are available for investigating magnesium concentration changes in mitochondria.
In this study, we have developed a novel Mg2+–selective fluorescent probe based on the rhodamine skeleton (KMG-301), and shown that it is functional inside mitochondria in intact cells. Using this probe, Mg2+ transport across the mitochondrial membrane and Mg2+ concentration changes in the early phases of a cellular model of PD were analyzed.
Results and Discussion
Molecular design
In this work, a Mg2+–selective fluorescent probe that is functional in mitochondria was designed and synthesized. The rhodamine skeleton was selected as the chromophore, and a charged-beta-diketone moiety as the binding site for Mg2+ coordination. Rhodamine with its cationic charge is known to localize to mitochondria because of their negative membrane potential [28]. Our previous work has shown that the charged-beta-diketone binding site has high selectivity for Mg2+ [29]. Several novel Mg2+–selective fluorescent probes with the charged-bata-diketone binding site introduced in the form of an α-keto acid have been developed [13], [14], [30]. These probes enable the measurement of [Mg2+]i with high selectivity and sensitivity, whereas commercially available Mg2+ indicators are less selective over Ca2+ [31]. Since Ca2+ concentrations in mitochondria are higher than in the cytosol and can vary over a wide range [32], it is important that Mg2+ indicators used in mitochondria are not affected by these Ca2+ concentration changes. Therefore, the highly Mg2+–selective charged-beta-diketone binding site was conjugated to the 9 position of the rhodamine skeleton, resulting in the novel probe KMG-301. This structure shows photoinduced electron transfer (PET)–type OFF-ON responses in the presence of Mg2+ ions. The synthetic scheme is shown in Figure 1.
Molecular properties of KMG-301
The absorbance and fluorescence spectra of KMG-301 were measured at a probe concentration of 5 µM in HEPES buffer (pH 7.2). Whereas 100 mM of Mg2+ did not alter the absorbance spectrum of KMG-301, it induced a 45-fold increase in fluorescence emission intensity compared to the ion-free condition (Figure 2A). The dissociation constant of this probe for Mg2+ was found to be 4.5 mM, which is a suitable value for detecting Mg2+ in mitochondria. The fluorescence quantum yield (Φfl) and the molar extinction coefficient (ε) were determined as 0.15 and 42100 M−1cm−1, respectively. Although KMG-301 showed a 3-fold fluorescence increase in the presence of 100 mM Ca2+, no fluorescence increase was observed at 1 mM Ca2+ (Figure 2B). Therefore, the physiologically relevant Ca2+ concentrations (∼100 µM) do not affect the fluorescence of KMG-301. Physiological concentration ranges of Na+ and K+ also have no effect on the fluorescence of KMG-301, both in the absence or presence of Mg2+ (Figure 2B and C). Moreover, other divalent cations did not influence the fluorescence signal at physiological concentrations (Figure 2C). KMG-301 was found to be sensitive to 1 mM of Ni2+ and Zn2+ (Figure S1). But in a physiological environment, concentrations of divalent cations other than Mg2+ and Ca2+ are below 1 µM whereas that of Mg2+ is 0.5–0.7 mM. Therefore, it can be concluded that KMG-301 is only sensitive to Mg2+ under intracellular and intramitochondrial conditions. The ion-free and Mg-bound fluorescence emission peaks of KMG-301 showed only a weak response to pH in the range of pH 6.5–9 (Figure 2D). The mitochondrial pH value is considered to be around 8.6. As a consequence, it can be concluded that pH (>6.0) and any other cations do not interfere with the measurement of Mg2+ concentrations using KMG-301 under physiologically normal intracellular conditions.
The localization of KMG-301 to mitochondria was confirmed in differentiated PC12 cells and hippocampal neurons. KMG-301 in the acetoxy methyl esterified form (KMG-301AM) (Figure 1) was applied to these cells. The localization of KMG-301 corresponded with that of MitoTracker Green FM (Figure 2E). This data indicates that KMG-301 was successfully localized in mitochondria in intact cells.
KMG-301 functionality in mitochondria
To confirm that KMG-301 is able to indicate changes in mitochondrial Mg2+ concentration ([Mg2+]mito), isolated mitochondria from PC12 cells were stained with KMG-301AM. Increasing the Mg2+ concentration around mitochondria from 0 mM to 1 mM induced a noticeable increase of KMG-301 fluorescence. A further increase in Mg2+ concentration around mitochondria from 1 mM to 5 mM induced a further increase in KMG-301 fluorescence (Figure 3A). In previous studies, we have demonstrated that carbonyl cyanide p-(trifluoromethoxy) phenylhydrazone (FCCP) induces Mg2+ release from mitochondria in PC12 cells [18]. Administration of FCCP induced a gradual decrease in KMG-301 fluorescence in mitochondria isolated from PC12 cells (Figure 3B). The time-course of this KMG-301 fluorescence decrease was similar to that of the FCCP-induced decrease in mitochondrial membrane potential in mitochondria isolated from PC12 cells (Figure S2). In mitochondria isolated from rat brain, FCCP also induced a gradual decrease in the fluorescence of KMG-301, whereas it induced a rapid decrease in the fluorescence of TMRE (Figure S2). It was confirmed that the FCCP-induced decrease in KMG-301 fluorescence was not caused by leaking of the dye from mitochondria. When the membrane potential partially recovered after washout of FCCP from mitochondria isolated from PC12 cells, the KMG-301 fluorescence also recovered significantly (Figure 3C and D). Mitochondria accumulated Mg2+ depending on the increase in their membrane potential, and KMG-301 could successfully detect the increase in Mg2+ concentration in mitochondria. This data allows to conclude that KMG-301 changes its fluorescence in response to the changes in [Mg2+]mito.
KMG-301 responds to Mg2+ concentration changes in mitochondria in intact cells
Mrs2 is known as a Mg2+–selective channel expressed in the mitochondrial inner membrane, and mitochondria accumulate Mg2+ via this channel depending on an electrochemical gradient [33]. To confirm that KMG-301 accumulates inside mitochondria in intact cells, changes in probe fluorescence in normal cells and in cells with suppressed Mrs2 expression levels were compared. Suppression of the Mrs2 expression levels was performed by transfection of a vector encoding both emerald GFP (EmGFP) and a miR RNAi for Mrs2 to PC12 cells (Figure S3). Because miR RNAi–expressing cells also express EmGFP, fluorescence changes of KMG-301 were measured only in EmGFP expressing cells. An increase in the extracellular Mg2+ concentration from 0 mM to 10 mM induced a remarkable increase in cytosolic Mg2+ concentration ([Mg2+]cyto) and a fluorescence increase of KMG-301 (Figures S4 and 4A gray line). This change in fluorescence of KMG-301 was caused by the change in [Mg2+]mito not by that in [Mg2+]cyto because no significant increase in fluorescence was observed in mitochondria-free areas (Figure S5). This increase in fluorescence of KMG-301 was significantly suppressed in miR RNAi–expressing cells (Figure 4A black line and B). This data not only indicates that KMG-301 was successfully internalized in mitochondria and detected the changes in [Mg2+]mito in intact cells, but also that Mrs2 plays an important role in Mg2+ accumulation in mitochondria.
It was also confirmed that KMG-301 is not released from mitochondria upon depolarization of the mitochondrial membrane potential. Rhodamine123 was used in a control experiment. Rhodamine 123 is a cell–permeable cationic fluorescent dye and widely used as a marker for mitochondria. This probe accumulates in the matrix of mitochondria dependent on their membrane potential. Upon depolarization of the mitochondrial membrane potential, Rhodamine 123 is released into the cytosol and the extracellular medium. Whereas FCCP induced a decrease in the fluorescence intensity of Rhodamine 123 in the cell body (presence of mitochondria), it induced an increase in the nucleus area (no mitochondria; Figure 5A and C). This indicates that the probe released from mitochondria caused an increase in the probe concentration in the cytosol and the nucleus, accompanied by a fluorescence increase in the same areas. On the other hand, whereas FCCP also induced a decrease in the fluorescence intensity of KMG-301 in the cell body, no increase in fluorescence was observed in the nucleus area of PC12 cells (Figure 5B and C). This indicates that KMG-301 accumulated in mitochondria and was not released from mitochondria by depolarization of the mitochondrial membrane potential. KMG-301AM successfully accumulates in mitochondria and is then hydrolyzed to KMG-301. Since the mitochondrial membrane is impermeable to KMG-301, it is not released upon depolarization of the mitochondrial membrane potential. Therefore, it can be concluded that KMG-301 is a Mg2+–selective fluorescent probe functional in mitochondria in intact cells. To the best of our knowledge, this is the first reported method for visualization of changes in [Mg2+]mito in intact cells.
Imaging of intracellular Mg2+ mobilization from mitochondria
Because the excitation and emission spectra of KMG-301 are different from those of the cytosolic Mg2+ probe KMG-104, it is possible to simultaneously observe the fluorescence of both probes. The interaction between the cytosolic and mitochondrial Ca2+ concentrations was observed and analyzed with simultaneous use of fura-2 and rhod-2 [34], [35]. These studies have clarified the contribution of mitochondria to Ca2+–buffering and Ca2+ mobilization. In this study, Mg2+ transport across the mitochondrial membrane was visualized by simultaneous application of KMG-104AM and KMG-301AM.
In our previous study, FCCP–induced Mg2+ release from mitochondria was shown by comparing the changes in [Mg2+]cyto around mitochondria with those in areas with no mitochondria [18]. Because KMG-301 allows to measure the changes in [Mg2+]mito directly, in this study, the changes in [Mg2+]cyto and [Mg2+]mito were measured Moreover, Mg2+ dynamics were compared in differentiated PC12 cells and in hippocampal neurons. In differentiated PC12 cells, [Mg2+]cyto increased for 1 min after FCCP administration and maintained a high value, whereas [Mg2+]mito decreased for more than 4 minutes after FCCP treatment (Figures 6A and B). In hippocampal neurons, [Mg2+]mito decreased only for 30 seconds after FCCP treatment and kept its low value, although [Mg2+]cyto increased for about 3 minutes (Figures 6C and D). Although the FCCP–induced decrease in [Mg2+]mito and increase in [Mg2+]cyto were observed both in differentiated PC12 cells and in hippocampal neurons, the time-course of concentration changes varied with the cell type. Because the time-courses of the depolarization of the mitochondrial membrane potential also varied with these cell types (Figure S6), it could be one of the reasons for the variation in Mg2+ transport. Moreover, these simultaneous measurements of changes in [Mg2+]cyto and [Mg2+]mito revealed that the time-course of the [Mg2+]cyto increase and the [Mg2+]mito decrease is not symmetric. Since the Mg2+ concentration is regulated by Mg2+ entry, Mg2+ efflux, buffering and compartmentation [7], [36], it seems that those differences in the Mg2+ concentration changes are caused by the cell type dependent differences in the balance of these mechanisms and the intracellular compartments.
Mg2+ entry into cells is mediated primarily by ion channels. Recently, many types of Mg2+–permeable channels have been identified [4], [37]. Some of them alter their expression levels or localization based on the environmental Mg2+ concentration. Buffering and muffling of increased [Mg2+]cyto are carried out mainly by Mg2+ extrusion via the Na+/Mg2+ exchanger and Mg2+ binding to ATP [38]. In PC12 cells, Mg2+ is extruded via the Na+/Mg2+ exchanger after FCCP administration [17]. It was estimated that almost 1/3 of Mg2+ muffling is due to Mg2+ binding to ATP and another 1/3 is due to Na+/Mg2+ exchange in leech neurons [39]. One part of the remaining 1/3 is expected to result from sequestration by mitochondria. Here, it was demonstrated that mitochondria also accumulate Mg2+ (Figure 4). Mrs2 plays an important role in this accumulation, because knockdown of this protein significantly suppressed the increase in [Mg2+]mito (Figure 4). This result is consistent with a study on isolated mitochondria [40]. It was also suggested that the endoplasmic reticulum accumulates Mg2+ [41]. The golgi apparatus and endosomes have Mg2+ transport proteins [37]. It could be possible that these organelles also participate in the Mg2+ buffering mechanism. [Mg2+]mito is regulated by Mrs2 and the ATP-Mg/Pi carrier in the mitochondrial inner membrane. This antiporter electroneutrally mediates Mg2+ transport depending on the concentration gradients of Pi and ATP [23]. The ATP concentration also affects the Mg2+ concentration [38]. Moreover, it was reported that unidentified Mg2+–binding proteins exist in the intermembrane space of mitochondria [42]. A balance of all those mechanisms controls the Mg2+ concentrations in the cytosol and in mitochondria with the possibility of further mechanisms being involved. Simultaneous measurements of [Mg2+]cyto and [Mg2+]mito enable the comparison of the Mg2+ dynamics in these two compartments and revealed that a collapse of the mitochondrial membrane potential induces the perturbation of Mg2+ concentrations in the cytosol and mitochondria.
PD inducible substance causes Mg2+ decrease in mitochondria
In dopaminergic cells, 1-methyl-4-phenylpyridinium ion (MPP+)–induced cell death is an excellent model of PD. Because PC12 cells are dopaminergic cells, MPP+–induced cell death in PC12 cells has been widely used for investigations of the mechanisms of neurodegeneration in PD [43], [44]. Since a mitochondria dysfunction was reported in PD patients and in MPP+–treated PC12 cells [44], [45], it is likely that [Mg2+]mito in PD patients and MPP+–treated cells were perturbed. To confirm this hypothesis, changes in [Mg2+]mito in response to MPP+ were measured in differentiated PC12 cells. After administration of MPP+, [Mg2+]mito decreased gradually (Figure 7A). The time-course of Mg2+ release from mitochondria was similar to that of the depolarization in the mitochondrial membrane potential (Figure S7). MPP+ in the range of 0.1–5 mM caused a Mg2+ release from mitochondria in a dose–dependent manner (Figure 7B). KMG-301 was bleached less than 5% in 10 minutes. In differentiated PC12 cells, 0.5–10 mM MPP+ induces cell death in a dose–dependent manner in 24 hours [46]. MPP+–induced Mg2+ release from mitochondria was observed in a concentration range consistent with the previous report. Because MPP+ acts as an inhibitor of the mitochondrial electron transfer chain, the mitochondrial membrane potential collapsed in MPP+–treated PC12 cells [47]. Therefore, it is likely that MPP+–induced Mg2+ release from mitochondria was caused by a decrease in the mitochondrial membrane potential, which is the same mechanism as in the case of FCCP–induced Mg2+ release from mitochondria. Because a decline of mitochondrial function is also observed in PD patients [45], this Mg2+ release from mitochondria might also occur in the neurons of PD patients. As described above, Mg2+ efflux from mitochondria results in Mg2+ extrusion from cells via the Na+/Mg2+ exchanger, and thus in a decrease of cellular Mg2+. These observations imply that the cellular Mg2+ content is decreased in the early phase of MPP+–induced cell death in PC12 cells and during neurodegeneration in PD.
In some studies, the deficiency of Mg2+ and PD were found to be closely related. PD–like dopaminergic neuronal loss was observed in the rat brain after exposure to low magnesium intake over generations [48]. It was also reported that the Mg2+ concentration is lowered in the brain of PD patients [26]. These reports suggest that low Mg2+ uptake to neurons and/or Mg2+ efflux from neurons are related to PD. Because Mg2+ exerts a preventive effect against MPP+–induced neuronal degeneration in rat dopaminergic neurons [49], the loss of cellular Mg2+ seems to accelerate the process of MPP+–induced cell death and neuronal degeneration in PD. Thus, Mg2+ release from mitochondria reported here seems to be a crucial event in the model of PD.
Materials and Methods
Ethics statement
All animal procedures were approved by the ethical committee of Keio University (permit number is 09106-(1)).
Synthesis
The organic synthesis of KMG-301 is described in the supporting information (Text S1).
Measurement of probe properties
Absorption measurements were performed on a U-2001 spectrophotometer (HITACHI, Tokyo, Japan). For the determination of the fluorescence quantum yield (Φfl), rhodamine101 (Φfl = 0.96) was used as fluorescence standard. Φfl and ε were measured in 100 mM HEPES buffer (pH 7.2) containing 100 mM Mg2+. Ion selectivity, pH sensitivity and fluorescence spectra were measured using a SPECTRAMAX GEMINI XS fluorescence microplate reader (Molecular Devices, Mountain View, CA, USA). The fluorescence of 5 µM KMG-301 was measured in 100 mM HEPES buffer (pH 7.2) with or without metal ions to estimate the ion selectivity. The effect of pH on the fluorescence of 5 µM KMG-301 was measured in 100 mM MES buffer (pH 5.5–7.0) or 100 mM HEPES buffer (pH 7.5–9.5) with or without 100 mM Mg2+. Excitation was performed at 540 nm and fluorescence emission was measured from 570 to 700 nm. The fluorescence emission intensity at 590 nm was used as the signal in the various experiments.
Cell culture
The primary culture of hippocampal neurons was prepared from day 17–19 embryonic Wistar rats (Charles River Laboratories Japan, Tokyo, Japan). Hippocampi were excised and submerged in ice-cold PBS(-). The hippocampal neurons were dissociated using dissociation solution (Sumitomo Bakelite Co., Tokyo, Japan), and plated on poly-D-lysine (PDL; Sigma-Aldrich, St. Louis, MO, USA)–coated glass bottom dishes (Iwaki, Tokyo, Japan), and cultured in neurobasal medium supplemented with B-27, 2 mM L-glutamine, 50 U/ml penicillin and 50 µg/ml streptomycin (all from Invitrogen, Carlsbad, CA, USA). Cultures were maintained at 37°C in a humidified atmosphere of 5% CO2. Cells were cultured for a minimum of seven days before experimental use.
PC12 cells were obtained from RIKEN Tsukuba Institute, and cultured in DMEM containing 10% horse serum, 5% FBS, 50 U/ml penicillin and 50 µg/ml streptomycin. For experimental use, cells were cultured on PDL–coated glass bottom dishes. In some experiments, cells were differentiated by culturing in serum–free medium with 50 ng/ml NGF for 5 days.
Isolation of mitochondria
Mitochondria were isolated from PC12 cells and rat brain (E19) using the Mitochondria Isolation Kit (BioChain Institute Inc., Gibbstown, NJ, USA). In short, cells were suspended in Mitochondria Isolation Buffer and homogenized with a Dounce homogenizer on ice. The homogenate was centrifuged 600×g for 10 min at 4°C, and the supernatant was further centrifuged at 12,000×g for 15 min at 4°C. The pellet was suspended in Mitochondria Storage Buffer and placed on Cell-Tak (BD Biosciences, Franklin Lakes, NJ, USA)–coated glass bottom dishes, and incubated 30–90 min on ice to embed on glass.
Fluorescence measurements
For optical imaging, 20 µM KMG-301AM was applied to cells in Hanks' balanced salt solutions (HBSS) containing (in mM): NaCl, 137; KCl, 5.4; CaCl2, 1.3; MgCl2, 0.5; MgSO4, 0.4; Na2HPO4, 0.3; KH2PO4, 0.4; NaHCO3, 4.2; D-glucose, 5.6; HEPES, 5 (pH adjusted to 7.4 with NaOH) for 10 min on ice, so that hydrolysis of the acetoxymethyl ester by esterase present in the cytosol would be avoided [50]. Then, the cells were washed twice with HBSS and incubated for 15 min at 37°C to allow for complete hydrolysis of the acetoxymethyl ester form in mitochondria. For the simultaneous use of KMG-104AM and KMG-301AM, cells were incubated with 5 µM KMG-104AM in HBSS for 30 min at 37°C, and then stained with KMG-301AM. For simultaneous use of KMG-301AM and MitoTracker Green FM, KMG-301–loaded cells were incubated with 5 nM MitoTracker Green FM for 10 min at 37°C, and then the cells were washed twice with HBSS. Rhodamine 123 was used at 100 nM, which is a non-quenching concentration. Cells were incubated with Rhodamine 123 in HBSS for 30 min at 37°C. Then the cells were washed twice with HBSS and incubated for 15 min in 37°C.
Isolated mitochondria were incubated with 20 µM KMG-301AM in Mitochondria Imaging Buffer (MIB) containing (in mM): KCl, 125; K2HPO4, 2; MgCl2, 1; HEPES, 5; EDTA, 0.02 (pH adjusted to 7.2 with KOH) or Mg2+-free MIB (without MgCl2) for 20 min at 37°C. Then, mitochondria were washed twice with MIB and further incubated for 15 min at 37°C.
Fluorescence imaging experiments were performed using a confocal laser scanning microscope system (FluoView FV1000; Olympus, Tokyo, Japan) mounted on an inverted microscope (IX81; Olympus) with 40× and 60× oil–immersion objective lenses. KMG-301 was excited at 559 nm from a laser diode, and the signal was observed at 600–700 nm. In the simultaneous measurement, KMG-104 and KMG-301 were excited at 488 nm from an Argon laser and 559 nm, respectively. Fluorescence was separated using a 560 nm dichroic mirror and observed at 500–545 nm and 600–700 nm, respectively. Fluorescent images were acquired and analyzed with the FluoView software package (Olympus). Fluorescence differences were calculated as the mean intensity over a defined region of interest (ROI) containing the cell body of each cell.
Knockdown of Mrs2 protein
miR RNAi–mediated knockdown was performed using the BLOCK-iT™ PolII miR RNAi Expression Vector Kit with EmGFP (Invitrogen). The miR RNAis sequences are listed in the supporting information. The expression vector was transfected to PC12 cells by electroporation using Neon (Invitrogen). Experiments were performed 4-days after transfection. The expression of miR RNAi was confirmed by the co-expression of EmGFP. In the fluorescence measurements, the fluorescence of KMG-301 was observed only in EmGFP–expressing cells.
Statistical analyses
Significant differences were determined by using Tukey's test for multiple comparisons. The p values less than 0.05 were considered as being significantly different.
Supporting Information
Footnotes
Competing Interests: The authors have declared that no competing interests exist.
Funding: This research was supported by a Strategic Research Foundation Grant-aided Project for Private Universities from Ministry of Education, Culture, Sports, Science, and Technology, Japan (MEXT), 2008-2012, (S0801008) (http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
References
- 1.Romani A, Scarpa A. Regulation of cell magnesium. Arch Biochem Biophys. 1992;298:1–12. doi: 10.1016/0003-9861(92)90086-c. [DOI] [PubMed] [Google Scholar]
- 2.Chaudhary DP, Sharma R, Bansal DD. Implications of magnesium deficiency in type 2 diabetes: a review. Biol Trace Elem Res. 2010;134:119–129. doi: 10.1007/s12011-009-8465-z. [DOI] [PubMed] [Google Scholar]
- 3.Shi J, Krishnamoorthy G, Yang Y, Hu L, Chaturvedi N, et al. Mechanism of magnesium activation of calcium-activated potassium channels. Nature. 2002;418:876–880. doi: 10.1038/nature00941. [DOI] [PubMed] [Google Scholar]
- 4.Nadler MJ, Hermosura MC, Inabe K, Perraud AL, Zhu Q, et al. LTRPC7 is a Mg.ATP-regulated divalent cation channel required for cell viability. Nature. 2001;411:590–595. doi: 10.1038/35079092. [DOI] [PubMed] [Google Scholar]
- 5.Ko YH, Hong S, Pedersen PL. Chemical mechanism of ATP synthase. Magnesium plays a pivotal role in formation of the transition state where ATP is synthesized from ADP and inorganic phosphate. J Biol Chem. 1999;274:28853–28856. doi: 10.1074/jbc.274.41.28853. [DOI] [PubMed] [Google Scholar]
- 6.Wolf FI, Trapani V. Cell (patho)physiology of magnesium. Clin Sci (Lond) 2008;114:27–35. doi: 10.1042/CS20070129. [DOI] [PubMed] [Google Scholar]
- 7.Romani A. Regulation of magnesium homeostasis and transport in mammalian cells. Arch Biochem Biophys. 2007;458:90–102. doi: 10.1016/j.abb.2006.07.012. [DOI] [PubMed] [Google Scholar]
- 8.Sontia B, Touyz RM. Arch Biochem Biophys; 2006. Role of magnesium in hypertension. [DOI] [PubMed] [Google Scholar]
- 9.Romani AM, Scarpa A. Regulation of cellular magnesium. Front Biosci. 2000;5:D720–734. doi: 10.2741/romani. [DOI] [PubMed] [Google Scholar]
- 10.Stout AK, Reynolds IJ. High-affinity calcium indicators underestimate increases in intracellular calcium concentrations associated with excitotoxic glutamate stimulations. Neuroscience. 1999;89:91–100. doi: 10.1016/s0306-4522(98)00441-2. [DOI] [PubMed] [Google Scholar]
- 11.van de Put FH, Elliott AC. Imaging of intracellular calcium stores in individual permeabilized pancreatic acinar cells. Apparent homogeneous cellular distribution of inositol 1,4,5-trisphosphate-sensitive stores in permeabilized pancreatic acinar cells. J Biol Chem. 1996;271:4999–5006. doi: 10.1074/jbc.271.9.4999. [DOI] [PubMed] [Google Scholar]
- 12.Trapani V, Farruggia G, Marraccini C, Iotti S, Cittadini A, et al. Intracellular magnesium detection: imaging a brighter future. Analyst. 2010;135:1855–1866. doi: 10.1039/c0an00087f. [DOI] [PubMed] [Google Scholar]
- 13.Komatsu H, Iwasawa N, Citterio D, Suzuki Y, Kubota T, et al. Design and synthesis of highly sensitive and selective fluorescein-derived magnesium fluorescent probes and application to intracellular 3D Mg2+ imaging. J Am Chem Soc. 2004;126:16353–16360. doi: 10.1021/ja049624l. [DOI] [PubMed] [Google Scholar]
- 14.Suzuki Y, Komatsu H, Ikeda T, Saito N, Araki S, et al. Design and synthesis of Mg2+-selective fluoroionophores based on a coumarin derivative and application for Mg2+ measurement in a living cell. Analytical Chemistry. 2002;74:1423–1428. doi: 10.1021/ac010914j. [DOI] [PubMed] [Google Scholar]
- 15.Zhou H, Clapham DE. Mammalian MagT1 and TUSC3 are required for cellular magnesium uptake and vertebrate embryonic development. Proc Natl Acad Sci U S A. 2009;106:15750–15755. doi: 10.1073/pnas.0908332106. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16.Jin J, Desai BN, Navarro B, Donovan A, Andrews NC, et al. Deletion of Trpm7 disrupts embryonic development and thymopoiesis without altering Mg2+ homeostasis. Science. 2008;322:756–760. doi: 10.1126/science.1163493. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17.Kubota T, Tokuno K, Nakagawa J, Kitamura Y, Ogawa H, et al. Na+/Mg2+ transporter acts as a Mg2+ buffering mechanism in PC12 cells. Biochemical and Biophysical Research Communications. 2003;303:332–336. doi: 10.1016/s0006-291x(03)00346-2. [DOI] [PubMed] [Google Scholar]
- 18.Kubota T, Shindo Y, Tokuno K, Komatsu H, Ogawa H, et al. Mitochondria are intracellular magnesium stores: investigation by simultaneous fluorescent imagings in PC12 cells. Biochim Biophys Acta. 2005;1744:19–28. doi: 10.1016/j.bbamcr.2004.10.013. [DOI] [PubMed] [Google Scholar]
- 19.Shindo Y, Fujimoto A, Hotta K, Suzuki K, Oka K. Glutamate-induced calcium increase mediates magnesium release from mitochondria in rat hippocampal neurons. J Neurosci Res. 2010;88:3125–3132. doi: 10.1002/jnr.22467. [DOI] [PubMed] [Google Scholar]
- 20.Panov A, Scarpa A. Mg2+ control of respiration in isolated rat liver mitochondria. Biochemistry. 1996;35:12849–12856. doi: 10.1021/bi960139f. [DOI] [PubMed] [Google Scholar]
- 21.Schindl R, Weghuber J, Romanin C, Schweyen RJ. Mrs2p forms a high conductance Mg2+ selective channel in mitochondria. Biophys J. 2007;93:3872–3883. doi: 10.1529/biophysj.107.112318. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22.Zsurka G, Gregan J, Schweyen RJ. The human mitochondrial Mrs2 protein functionally substitutes for its yeast homologue, a candidate magnesium transporter. Genomics. 2001;72:158–168. doi: 10.1006/geno.2000.6407. [DOI] [PubMed] [Google Scholar]
- 23.Satrustegui J, Pardo B, Del Arco A. Mitochondrial transporters as novel targets for intracellular calcium signaling. Physiol Rev. 2007;87:29–67. doi: 10.1152/physrev.00005.2006. [DOI] [PubMed] [Google Scholar]
- 24.Boska MD, Welch KM, Barker PB, Nelson JA, Schultz L. Contrasts in cortical magnesium, phospholipid and energy metabolism between migraine syndromes. Neurology. 2002;58:1227–1233. doi: 10.1212/wnl.58.8.1227. [DOI] [PubMed] [Google Scholar]
- 25.Andrasi E, Pali N, Molnar Z, Kosel S. Brain aluminum, magnesium and phosphorus contents of control and Alzheimer-diseased patients. J Alzheimers Dis. 2005;7:273–284. doi: 10.3233/jad-2005-7402. [DOI] [PubMed] [Google Scholar]
- 26.Yasui M, Kihira T, Ota K. Calcium, magnesium and aluminum concentrations in Parkinson's disease. Neurotoxicology. 1992;13:593–600. [PubMed] [Google Scholar]
- 27.Beal MF. Mitochondria take center stage in aging and neurodegeneration. Ann Neurol. 2005;58:495–505. doi: 10.1002/ana.20624. [DOI] [PubMed] [Google Scholar]
- 28.Scaduto RC, Grotyohann LW. Measurement of mitochondrial membrane potential using fluorescent rhodamine derivatives. Biophys J. 1999;76:469–477. doi: 10.1016/S0006-3495(99)77214-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29.Shoda T, Kikuchi K, Kojima H, Urano Y, Komatsu H, et al. Development of selective, visible light-excitable, fluorescent magnesium ion probes with a novel fluorescence switching mechanism. Analyst. 2003;128:719–723. doi: 10.1039/b212835g. [DOI] [PubMed] [Google Scholar]
- 30.Komatsu H, Miki T, Citterio D, Kubota T, Shindo Y, et al. Single molecular multianalyte (Ca2+, Mg2+) fluorescent probe and applications to bioimaging. J Am Chem Soc. 2005;127:10798–10799. doi: 10.1021/ja0528228. [DOI] [PubMed] [Google Scholar]
- 31.Raju B, Murphy E, Levy LA, Hall RD, London RE. A fluorescent indicator for measuring cytosolic free magnesium. Am J Physiol. 1989;256:C540–548. doi: 10.1152/ajpcell.1989.256.3.C540. [DOI] [PubMed] [Google Scholar]
- 32.Walsh C, Barrow S, Voronina S, Chvanov M, Petersen OH, et al. Modulation of calcium signalling by mitochondria. Biochim Biophys Acta. 2009;1787:1374–1382. doi: 10.1016/j.bbabio.2009.01.007. [DOI] [PubMed] [Google Scholar]
- 33.Kolisek M, Zsurka G, Samaj J, Weghuber J, Schweyen R, et al. Mrs2p is an essential component of the major electrophoretic Mg2+ influx system in mitochondria. Embo J. 2003;22:1235–1244. doi: 10.1093/emboj/cdg122. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34.Drummond RM, Tuft RA. Release of Ca2+ from the sarcoplasmic reticulum increases mitochondrial [Ca2+] in rat pulmonary artery smooth muscle cells. J Physiol. 1999;516(Pt1):139–147. doi: 10.1111/j.1469-7793.1999.139aa.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35.Jaiswal MK, Zech WD, Goos M, Leutbecher C, Ferri A, et al. Impairment of mitochondrial calcium handling in a mtSOD1 cell culture model of motoneuron disease. BMC Neurosci. 2009;10:64. doi: 10.1186/1471-2202-10-64. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36.Cole DE, Quamme GA. Inherited disorders of renal magnesium handling. J Am Soc Nephrol. 2000;11:1937–1947. doi: 10.1681/ASN.V11101937. [DOI] [PubMed] [Google Scholar]
- 37.Quamme GA. Molecular identification of ancient and modern mammalian magnesium transporters. Am J Physiol Cell Physiol. 2010;298:C407–429. doi: 10.1152/ajpcell.00124.2009. [DOI] [PubMed] [Google Scholar]
- 38.Gabriel TE, Gunzel D. Quantification of Mg2+ extrusion and cytosolic Mg2+-buffering in Xenopus oocytes. Arch Biochem Biophys. 2007;458:3–15. doi: 10.1016/j.abb.2006.07.007. [DOI] [PubMed] [Google Scholar]
- 39.Gunzel D, Zimmermann F, Durry S, Schlue WR. Apparent intracellular Mg2+ buffering in neurons of the leech Hirudo medicinalis. Biophys J. 2001;80:1298–1310. doi: 10.1016/S0006-3495(01)76104-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40.Piskacek M, Zotova L, Zsurka G, Schweyen RJ. Conditional knockdown of hMRS2 results in loss of mitochondrial Mg(2+) uptake and cell death. J Cell Mol Med. 2009;13:693–700. doi: 10.1111/j.1582-4934.2008.00328.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41.Di Francesco A, Desnoyer RW, Covacci V, Wolf FI, Romani A, et al. Changes in magnesium content and subcellular distribution during retinoic acid-induced differentiation of HL60 cells. Arch Biochem Biophys. 1998;360:149–157. doi: 10.1006/abbi.1998.0937. [DOI] [PubMed] [Google Scholar]
- 42.Bogucka K, Wojtczak L. Binding of magnesium by proteins of the mitochondrial intermembrane compartment. Biochem Biophys Res Commun. 1976;71:161–167. doi: 10.1016/0006-291x(76)90263-1. [DOI] [PubMed] [Google Scholar]
- 43.Xu Z, Cawthon D, McCastlain KA, Duhart HM, Newport GD, et al. Selective alterations of transcription factors in MPP+-induced neurotoxicity in PC12 cells. Neurotoxicology. 2005;26:729–737. doi: 10.1016/j.neuro.2004.12.008. [DOI] [PubMed] [Google Scholar]
- 44.Cartelli D, Ronchi C, Maggioni MG, Rodighiero S, Giavini E, et al. Microtubule dysfunction precedes transport impairment and mitochondria damage in MPP+ -induced neurodegeneration. J Neurochem. 2010;115:247–258. doi: 10.1111/j.1471-4159.2010.06924.x. [DOI] [PubMed] [Google Scholar]
- 45.Schapira AH. Mitochondrial disease. Lancet. 2006;368:70–82. doi: 10.1016/S0140-6736(06)68970-8. [DOI] [PubMed] [Google Scholar]
- 46.Liou AK, Zhou Z, Pei W, Lim TM, Yin XM, et al. BimEL up-regulation potentiates AIF translocation and cell death in response to MPTP. Faseb J. 2005;19:1350–1352. doi: 10.1096/fj.04-3258fje. [DOI] [PubMed] [Google Scholar]
- 47.Selvaraj S, Watt JA, Singh BB. TRPC1 inhibits apoptotic cell degeneration induced by dopaminergic neurotoxin MPTP/MPP(+). Cell Calcium. 2009;46:209–218. doi: 10.1016/j.ceca.2009.07.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48.Oyanagi K, Kawakami E, Kikuchi-Horie K, Ohara K, Ogata K, et al. Magnesium deficiency over generations in rats with special references to the pathogenesis of the Parkinsonism-dementia complex and amyotrophic lateral sclerosis of Guam. Neuropathology. 2006;26:115–128. doi: 10.1111/j.1440-1789.2006.00672.x. [DOI] [PubMed] [Google Scholar]
- 49.Hashimoto T, Nishi K, Nagasao J, Tsuji S, Oyanagi K. Magnesium exerts both preventive and ameliorating effects in an in vitro rat Parkinson disease model involving 1-methyl-4-phenylpyridinium (MPP+) toxicity in dopaminergic neurons. Brain Res. 2008;1197:143–151. doi: 10.1016/j.brainres.2007.12.033. [DOI] [PubMed] [Google Scholar]
- 50.Trollinger DR, Cascio WE, Lemasters JJ. Mitochondrial calcium transients in adult rabbit cardiac myocytes: inhibition by ruthenium red and artifacts caused by lysosomal loading of Ca(2+)-indicating fluorophores. Biophys J. 2000;79:39–50. doi: 10.1016/S0006-3495(00)76272-2. [DOI] [PMC free article] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.